ARCHIVES

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 28 No. 35 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

Nevins Reverses Position, Claims Potti Manipulated Data For Basis of Clinical Trials

February 17, 2012

Congress Funds NIH Through Fiscal Year, Re-Opening Agency With 5.7% Increase

January 12, 1996

Tobacco Control Bill Requires Stronger Warnings

August 10, 1990

Marvin Schneiderman To Retire March 1

February 8, 1980

ASCO Updates Guideline On Follow-Up Management

October 27, 2006

Advisers Discuss What To Do About Physician-Scientists

May 1, 1992